Pure Global AI
NCT06150300Not yet recruiting

Examining the Effects of a Remote Pulmonary Rehabilitation Program in the Severe Asthma Population.

STAPLE (Severe asThmA PuLmonary rEhab): Examining the Effects of a Remote Pulmonary Rehabilitation Program in the Severe Asthma Population.
University of SaskatchewanClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Asthma
Drug/Device/Intervention
Pulmonary rehab program
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Saskatchewan
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2024
End date
Dec 31, 2026
Enrollment
34 participants
Primary outcome

CPET

Summary

This is a randomized control trial evaluating the effect of a novel mobile
 application-delivered pulmonary rehabilitation program in adult severe asthma patients. The
 intervention will include eight weeks of exercise videos that progress in difficulty, as well
 as asthma-specific educational content. The primary outcome measure is change in functional
 exercise capacity as measured by six-minute walk distance. Secondary outcome measures will
 include evaluation of overall feasibility, and change in CPET parameters such as VO2max.
 Change in asthma control questionnaire (ACQ), asthma quality of life questionnaire (AQLQ) and
 PRAISE self-efficacy score will also be evaluated.

ICD-10 classifications
AsthmaAsthma, unspecifiedNonallergic asthmaMixed asthmaPredominantly allergic asthma
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06150300
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06150300 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Saskatchewan and is currently Not yet recruiting. The study focuses on Asthma. Target enrollment is 34 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.